Advertisement Corgenix unveils automated HA test kit - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Corgenix unveils automated HA test kit

Corgenix Medical has unveiled a new Hyaluronic Acid (HA) immmunoturbidimetric test kit to validate chronic liver disease.

The HA test kit measures blood levels of hyaluronic acid and is mainly expressed to be used on automated chemistry analyzers.

As per the signed Joint Product Development Agreement (JPDA) in 2010, the automated HA test kit has been developed under the partnership of the ELITech Group.

Through ELITech the new HA test kit will be available through out the world and it will be available in the US for research purposes only through Corgenix.

Corgenix president and CEO Douglass Simpson said they have a very active development program with ELITech and over the next few years they will bring additional new and exciting products.

The company said HA Immmunoturbidimetric test kit is expected to be CE-marked and is not FDA cleared or approved for diagnostic use in the US.